Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-11-000943
Filing Date
2011-05-16
Accepted
2011-05-16 14:28:50
Documents
5
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 AOXING PHARMACEUTICAL COMPANY, INC. FORM 10-Q MARCH 31, 2011 axn20110331.htm 10-Q 511552
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SOX OF 2 axn20110331ex31-1.htm EX-31.1 9946
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SOX OF 2 axn20110331ex31-2.htm EX-31.2 10267
4 CERTIFICATE OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C.SS.1350 axn20110331ex32-1.htm EX-32.1 5626
5 CERTIFICATE OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.SS.1350 axn20110331ex32-2.htm EX-32.2 5724
  Complete submission text file 0001096906-11-000943.txt   544455
Mailing Address 15 EXCHANGE PLACE, SUITE 500 JERSEY CITY NJ 07302
Business Address 15 EXCHANGE PLACE, SUITE 500 JERSEY CITY NJ 07302 646-367-1747
AOXING PHARMACEUTICAL COMPANY, INC. (Filer) CIK: 0001060426 (see all company filings)

EIN.: 650636168 | State of Incorp.: FL | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-32674 | Film No.: 11845664
SIC: 2834 Pharmaceutical Preparations